---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-068363"
form_type: "8-K"
ticker: "MDAI"
cik: "0001833498"
company_name: "Spectral AI, Inc."
filed_at: "2024-08-13T23:59:59+00:00"
generated_at: "2026-05-31T09:48:35.692715+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Spectral AI posts investor deck showing 2024E rev ~$28M (+56% YoY) and 85% burn trial enrollment

## Summary
- H1 2024 revenue $13.8M; FY 2023 revenue $18M, FY 2024 expected ~$28M.
- Cash position $6.9M at June 30, 2024; $10M committed equity facility secured.
- Burn pivotal trial 85%+ enrolled (160 goal); enrollment completion expected Sept 2024.
- DeepView platform targets burn ($3.7B TAM) and diabetic foot ulcer ($11B TAM) markets.
- Joined Russell Microcap Index; 26 issued and 38 pending patents.

## SEC filing metadata
- accession: 0001213900-24-068363
- form_type: 8-K
- ticker: MDAI
- cik: 0001833498
- company_name: Spectral AI, Inc.
- filed_at: 2024-08-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1833498/000121390024068363/0001213900-24-068363-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1833498/000121390024068363/ea0211308-8k_spectral.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-068363
- JSON: https://secwatch.observer/filing/0001213900-24-068363.json
- Plain text: https://secwatch.observer/filing/0001213900-24-068363.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.